In a national trial of 570 adults, suicidal ideation declined within 1 week of starting Opioid use disorder meds. Both buprenorphine-naloxone and extended-release naltrexone helped, but buprenorphine showed stronger early effects.
Receipt of buprenorphine and naltrexone for opioid use disorder by race and ethnicity and insurance type - EurekAlert!
